E1	Or:T1 Arg:T48 Arg2:T49
E2	Condition:T2 Name:T51
E3	Observation:T3 Name:T52 Eq-Comparison:E4
E4	Eq-Comparison:T4 Value:T53 Operator:T54
E5	Observation:T5 Name:T56 Stability:T57
E6	Negation:T6 Negates:E7 Negates2:E26
E7	Condition:T7 Name:T58
E8	Or:T8 Arg:E7 Arg2:E26
E9	Condition:T9 Name:T59
E10	Condition:T10 Name:T60
E11	Condition:T11 Name:T61
E12	Eq-Comparison:T12 Operator:T62 Value:T63 Unit:T64 Per:T65
E13	Procedure:T13 Name:T67
E14	Modifier:T14 Modifies:E15
E15	Drug:T15
E16	Assertion:T16 Asserted:T68
E17	Observation:T17 Name:T69 Stability:T68
E18	Drug:T18 Name:T98 Dose:T70 Dose2:E19
E19	Eq-Comparison:T19 Operator:T71 Value:T72 Unit:T73 Per:T74
E20	Drug:T20 Name:T75
E21	Eq-Comparison:T21 Value:T76 Temporal-Unit:T77
E25	Drug:T25 Name:T79
E27	Drug:T27 Name:T81
E28	Drug:T28 Name:T82
E29	Drug:T29 Name:T102
E30	Drug:T30 Name:T84
E31	Or:T31 Arg:E30 Arg2:E32
E32	Drug:T32 Name:T85
E33	Or:T33 Arg:E32 Arg2:E34
E34	Drug:T34 Name:T86
E35	Allergy:T35 Name:E30 Name2:E32 Name3:E34
E36	Eq-Comparison:T36 Value:T87 Unit:T88
E37	Observation:T37 Name:T89 Eq-Comparison:E36
E38	Observation:T38 Name:T90 Eq-Comparison:E36
E39	Observation:T39 Name:T91 Eq-Comparison:E36
E40	Observation:T40 Name:T92
E41	Observation:T41 Name:T93 Eq-Comparison:E36
E42	Observation:T42 Name:T94
E43	Exception:T43 From:E42 Except:E44 Except2:E45
E44	Condition:T44 Name:T95
E45	Observation:T45 Name:T96
E46	Exception:T46 From:E45 Except:E47
E47	Condition:T47 Name:T97
E26	Condition:T26 Name:T80
E48	Observation:T83 Eq-Comparison:E12
E49	Modifier:T66 Modifies:T67
E22	Drug:T22 Name:T23
E23	Provider:T24 Role:T78
E24	Observation:T99 Name:T100 Provider:E23
E50	Modifier:T101 Modifies:T102
T1	Or 36 34	and
T2	Condition 62 59	premenopausal
T3	Observation 74 69	BMI
T4	Eq-Comparison 80 73	29-
T5	Observation 97 87	Weight
T6	Negation 113 103	Not
T7	Condition 122 112	pregnant
T8	Or 124 113	/
T9	Condition 182 168	Ischemic heart disease
T10	Condition 220 206	Atherosclerotic valvular disease
T11	Condition 233 219	Smokers
T12	Eq-Comparison 262 244	>20 cigarettes per week
T13	Procedure 293 273	oophorectomy
T14	Modifier 310 290	Concomitant
T15	Drug 329 309	medications
T16	Assertion 338 318	can
T17	Observation 364 344	serum lipid profile
T18	Drug 396 374	fish oil
T19	Eq-Comparison 414 387	>3g per day
T20	Drug 438 407	STATINS
T21	Eq-Comparison 465 432	hold for 6 weeks
T25	Drug 515 478	Niacin
T27	Drug 563 526	thiazolidinediones
T28	Drug 589 550	Beta-blockers
T29	Drug 623 584	antipsychotics
T30	Drug 638 599	Lidocaine
T31	Or 641 602	or
T32	Drug 648 609	Niacin
T33	Or 650 610	/
T34	Drug 658 617	Niaspan
T35	Allergy 666 625	allergy
T36	Eq-Comparison 718 676	1.5 times upper limit of normal
T37	Observation 738 696	serum creatinine
T38	Observation 761 718	Alkaline phosphatase
T39	Observation 790 746	Aspartate aminotransferase
T40	Observation 796 751	AST
T41	Observation 826 778	Alanine aminotransferase
T42	Observation 832 783	ALT
T43	Exception 841 791	unless
T44	Condition 877 827	fatty liver disease
T45	Observation 895 844	Total bilirubin
T46	Exception 904 852	unless
T47	Condition 950 898	Gilbert's syndrome
T48	Life-Stage-And-Gender 32 30	Women
T49	Life-Stage-And-Gender 40 38	Men
T50	Life-Stage-And-Gender 48 45	Women
T51	Condition-Name 62 59	premenopausal
T52	Observation-Name 74 69	BMI
T53	Eq-Value 78 72	29
T54	Eq-Operator 80 73	-
T55	Eq-Value 84 75	37
T56	Observation-Name 97 87	Weight
T57	Stability 104 94	stable
T58	Condition-Name 122 112	pregnant
T59	Condition-Name 182 168	Ischemic heart disease
T60	Condition-Name 220 206	Atherosclerotic valvular disease
T61	Condition-Name 233 219	Smokers
T62	Eq-Operator 238 222	>
T63	Eq-Value 242 224	20
T64	Eq-Unit 253 235	cigarettes
T65	Eq-Temporal-Unit 262 244	week
T67	Procedure-Name 293 273	oophorectomy
T68	Stability 344 324	alter
T69	Observation-Name 364 344	serum lipid profile
T70	Polarity 382 360	High
T71	Eq-Operator 401 377	>
T72	Eq-Value 404 378	3
T73	Eq-Unit 406 379	g
T74	Eq-Temporal-Unit 414 387	day
T75	Drug-Name 438 407	STATINS
T76	Eq-Value 459 426	6
T77	Eq-Temporal-Unit 465 432	weeks
T79	Drug-Name 515 478	Niacin
T81	Drug-Name 563 526	thiazolidinediones
T82	Drug-Name 589 550	Beta-blockers
T84	Drug-Name 638 599	Lidocaine
T85	Drug-Name 648 609	Niacin
T86	Drug-Name 658 617	Niaspan
T87	Eq-Value 690 648	1.5
T88	Eq-Unit 718 676	upper limit of normal
T89	Observation-Name 738 696	serum creatinine
T90	Observation-Name 761 718	Alkaline phosphatase
T91	Observation-Name 790 746	Aspartate aminotransferase
T92	Observation-Name 796 751	AST
T93	Observation-Name 826 778	Alanine aminotransferase
T94	Observation-Name 832 783	ALT
T95	Condition-Name 877 827	fatty liver disease
T96	Observation-Name 895 844	Total bilirubin
T97	Condition-Name 950 898	Gilbert's syndrome
T26	Condition 132 120	nursing
T80	Condition-Name 132 120	nursing
T83	Observation 233 219	Smokers
T66	Modifier 280 260	Bilateral
T98	Drug-Name 396 374	fish oil
T22	Drug 534 497	Fibrates
T23	Drug-Name 534 497	Fibrates
T24	Provider 481 448	PCP
T78	Provider-Role 481 448	PCP
T99	Observation 492 459	approval
T100	Observation-Name 492 459	approval
T101	Modifier 608 569	Atypical
T102	Drug-Name 623 584	antipsychotics
A1	Assertion-Type-Value E16 hypothetical
A2	Life-Stage-And-Gender-Type T48 female
A3	Life-Stage-And-Gender-Type T49 male
A4	Life-Stage-And-Gender-Type T50 female
A5	Observation-Type-Value T52 vital
A6	Eq-Operator-Value T54 BETWEEN
A7	Observation-Type-Value T56 vital
A8	Stability-Value T57 stable
A9	Eq-Operator-Value T62 GT
A10	Eq-Temporal-Unit-Value T65 week
A12	Stability-Value T68 change
A13	Observation-Type-Value T69 lab
A14	Polarity-Value T70 high
A15	Eq-Operator-Value T71 GT
A16	Eq-Temporal-Unit-Value T74 day
A17	Eq-Temporal-Unit-Value T77 week
A18	Eq-Unit-Value T88 ref-range-normal
A19	Observation-Type-Value T89 lab
A20	Observation-Type-Value T90 lab
A21	Observation-Type-Value T91 lab
A22	Observation-Type-Value T92 lab
A23	Observation-Type-Value T93 lab
A24	Observation-Type-Value T94 lab
A25	Observation-Type-Value T96 lab
R1	If-Then Arg1:T50 Arg2:E2
R2	Caused-By Arg1:T68 Arg2:E15
R3	Equivalent-To Arg1:E19 Arg2:T70
R4	Abbrev-Of Arg1:E40 Arg2:E39
R5	Abbrev-Of Arg1:E42 Arg2:E41